Uwe Hehnke
Overview
Explore the profile of Uwe Hehnke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inzucchi S, Wanner C, Hehnke U, Zwiener I, Kaspers S, Clark D, et al.
Diabetes Care
. 2019 Feb;
42(4):e53-e55.
PMID: 30705060
No abstract available.
2.
Cooper M, Perkovic V, Groop P, Hocher B, Hehnke U, Meinicke T, et al.
J Hypertens
. 2018 Dec;
37(6):1294-1300.
PMID: 30540657
Objective: Concomitant treatment with angiotensin-converting enzyme (ACE) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors is increasingly common. Pharmacological studies have suggested a potential adverse drug interaction between ACE inhibitors and DPP-4...
3.
Inzucchi S, Kosiborod M, Fitchett D, Wanner C, Hehnke U, Kaspers S, et al.
Circulation
. 2018 Oct;
138(17):1904-1907.
PMID: 30354665
No abstract available.
4.
Nauck M, Araki A, Hehnke U, Plat A, Clark D, Khunti K
Int J Clin Pract
. 2018 Sep;
72(10):e13240.
PMID: 30216648
Aims: To investigate the risk of hypoglycaemia in people aged ≥65 years with type 2 diabetes mellitus (T2DM) treated with linagliptin, in the largest pooled analysis performed to date. Materials...
5.
Zinman B, Inzucchi S, Wanner C, Hehnke U, George J, Johansen O, et al.
Diabetologia
. 2018 May;
61(7):1522-1527.
PMID: 29713728
Aims/hypothesis: The global epidemic of type 2 diabetes affects women and men equally; however, the relative impact on the cardiovascular (CV) system appears greater for women than men when compared...
6.
Verma S, Mazer C, Al-Omran M, Inzucchi S, Fitchett D, Hehnke U, et al.
Circulation
. 2017 Nov;
137(4):405-407.
PMID: 29133602
No abstract available.
7.
Ning G, Bandgar T, Hehnke U, Lee J, Chan J
Adv Ther
. 2017 Aug;
34(9):2150-2162.
PMID: 28819835
Introduction: Asian patients with type 2 diabetes (T2D) are younger, leaner, and more likely to develop renal dysfunction than White populations. In this multiethnic analysis of data from phase 3...
8.
Chilton R, Tikkanen I, Hehnke U, Woerle H, Johansen O
Diabetes Obes Metab
. 2017 Apr;
19(11):1620-1624.
PMID: 28387058
In the EMPA-REG BP trial, empagliflozin significantly reduced systolic and diastolic blood pressure (SBP and DBP) compared with placebo at week 12 in patients with type 2 diabetes mellitus (T2DM)...
9.
Mu Y, Pan C, Fan B, Hehnke U, Zhang X, Zhang X, et al.
Diabetes Res Clin Pract
. 2017 Jan;
124:48-56.
PMID: 28088030
Aim: To assess efficacy/safety of initial linagliptin/metformin single-pill combination (SPC) therapies versus individual drug components over 24weeks in treatment-naïve Asian patients with type 2 diabetes mellitus and insufficient glycemic control....
10.
Lehrke M, Leiter L, Hehnke U, Thiemann S, Bhandari A, Meinicke T, et al.
J Diabetes Complications
. 2016 Jul;
30(7):1378-84.
PMID: 27396241
Aims: To examine the safety and efficacy of linagliptin in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) using pooled data from the global clinical trials...